TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
Clinical trial NCT05535192 · RECRUITING
Trial details
- NCT number
- NCT05535192
- Sponsor
- Dana-Farber Cancer Institute
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-20
- Primary completion
- 2027-09-30
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.